ZGGS-001

N/A

Report date: 2024/08/13 17:33:56

Base Information

Drug NameZGGS-001
Drug Alias NameZGGS-001ZGGS001GS-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockersTEK receptor tyrosine kinase antagonistsVascular endothelial growth factor receptor antagonists
TargetsProgrammed cell death protein 1TEK receptor tyrosine kinaseVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGensun Biopharma IncSuzhou Zelgen Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Zelgen Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A